Cellectis (CLLS) Tops Q4 EPS by 19c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.54), $0.19 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $3.08 million versus the consensus estimate of $4.95 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c
• PayPal (PYPL) stock: Risk-reward 'finally looks favorable' says Deutsche Bank